sacituzumab govitecan cmax

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
sacituzumab govitecan cmax	0.41	0.6	2144	56	26
sacituzumab	1.12	0.2	897	68	11
govitecan	1.1	0.6	1216	20	9
cmax	0.6	1	588	28	4

Keyword	CPC	PCC	Volume	Score
sacituzumab govitecan cmax	1.63	0.5	1038	1
sacituzumab govitecan clinical trial	0.37	1	6940	28
sacituzumab govitecan clatterbridge	0.14	0.9	1603	52
sacituzumab govitecan patient information	1.85	0.7	6974	75
sacituzumab govitecan prescribing information	0.95	0.4	6323	95
sacituzumab govitecan fda approval	0.35	0.3	1055	49
is sacituzumab govitecan chemotherapy	1.12	0.2	5143	66
sacituzumab-govitecan	1.59	0.7	6893	82
sacituzumab govitecan drug class	1.78	0.3	8571	50
sacituzumab govitecan phase i	1.17	1	4732	67
sacituzumab govitecan urothelial carcinoma	0.68	0.2	5062	9
sacituzumab govitecan bc cancer	1.18	0.6	3339	10
is sacituzumab govitecan immunotherapy	0.53	0.5	3143	26
sacituzumab govitecan breast cancer	0.14	0.2	9881	49
sacituzumab govitecan fda label	0.39	0.9	6305	74
sacituzumab govitecan mechanism of action	0.99	0.5	1104	31
sacituzumab govitecan breast cancer approval	0.29	0.4	6868	17
sacituzumab govitecan protocol nhs	0.73	0.7	9738	72
sacituzumab govitecan for bladder cancer	0.48	0.6	4848	88
sacituzumab govitecan lung cancer	1.42	0.7	1955	46
sacituzumab govitecan-hziy	1.52	0.6	8622	90
sacituzumab govitecan fiche patient	1.8	0.4	7716	38
sacituzumab govitecan plus pembrolizumab	0.52	0.1	5134	36
sacituzumab govitecan j code	1.14	0.2	3889	65
acces precoce sacituzumab govitecan	0.8	0.9	8830	88
sacituzumab govitecan brain metastases	1.43	0.4	8185	30